主 办:北 京 中 医 药 大 学
ISSN 1006-2157 CN 11-3574/R

JOURNAL OF BEIJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE ›› 2021, Vol. 44 ›› Issue (3): 203-208.doi: 10.3969/j.issn.1006-2157.2021.03.002

• Expert Opinion • Previous Articles     Next Articles

Evaluation of studies of prevention and treatment of combined allergic rhinitis and asthma syndrome with TCM*

Cui Hongsheng1, Lyu Mingsheng1,2, Wang Ji3, Bi Weibo1, Gong Xuefeng1,2   

  1. 1 Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing 100029, China;
    2 Beijing University of Chinese Medicine, Beijing 100029, China;
    3 National Institute of Traditional Chinese Medicine Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
  • Received:2020-11-20 Online:2021-03-30 Published:2021-03-30
  • Contact: Prof. Cui Hongsheng, M.D., Chief Physician, Doctoral Supervisor. Beijing University of Chinese Medicine Third Affiliated Hospital. No. 51 Xiaoguan Street, Chaoyang District, Beijing 100029. E-mail: hshcui@sina.com
  • Supported by:
    National Natural Science Foundation of China (No. 81973715, No. 82074390), Beijing Natural Science Foundation (No. 7202110)

Abstract: The combined allergic rhinitis and asthma syndrome (CARAS) is not only a typical allergic disease but a common and refractory disorder of the respiratory system with high prevalence rate and complex pathogenesis. Due to limited therapies, CARAS is prone to recurrent attacks. Traditional Chinese medicine (TCM), characterized by overall pattern differentiation and systemic therapy, has been proved to be valuable in the treatment of CARAS. Literature on CARAS was reviewed in terms of its etiology, pathogenesis, and treatment with TCM. Based on that, it is concluded that the special-diathesis constitution is the primary constitution of patients with CARAS, that latent pathogen attacks the lung is the core pathogenesis, constitution-disease-pattern differentiation is the way of diagnosis and treatment in clinical prevention and treatment, and the randomized controlled trial and large-sample real-world research would be the directions of future clinical study.

Key words: combined allergic rhinitis and asthma syndrome, etiology and pathogenesis, treatment research, clinical research idea

CLC Number: 

  • R256.1